Autosomal Dominant Polycystic Kidney Disease: Studies in Comorbidity
Studies on comorbidities seen with CKD reviewed here examine controlled vs uncontrolled gout, psychiatric diagnoses, and screening for intracranial aneurysm.
Comorbidites seen with chronic kidney disease can be devastating. In the slides below we highlight research from recent meetings and the literature on:â Prevalence of chronic kidney disease (CKD) in uncontrolled vs controlled gout â Psychiatric diagnoses in hospitalized ESKD patients â Screening for intracranial aneurysms in patients with ADPKD
Sotagliflozin in Patients with Type 1 Diabetes and CKD to be Discussed at October FDA AdComm Meeting
October 14th 2024Lexicon's sotagliflozin is on the October 31 docket for discussion by the FDA's Endocrinologic and Metabolic Drugs Advisory Committee; PDUFA goal date remains set for December 20.
